lymphocytic leukaemia

lymphocytic leukaemia

(1) Acute lymphocytic leukaemia, see there. 
(2) Chronic lymphocytic leukaemia, see there.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

Lymphocytic leukaemia

A LEUKEMIA in which the cells undergoing uncontrolled increase (proliferation) are LYMPHOCYTES. Chronic lymphocytic leukaemia is a variable disease: some patients require no treatment; others have a poor outcome. ZAP-70 estimations provide a guide to the prognosis.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
M2 EQUITYBITES-August 15, 2019-AstraZeneca gains FDA Breakthrough Therapy Designation for Calquence for chronic lymphocytic leukaemia
M2 PHARMA-August 15, 2019-AstraZeneca gains FDA Breakthrough Therapy Designation for Calquence for chronic lymphocytic leukaemia
The team created a compound using feverfew, a common flowering garden plant, to kill chronic lymphocytic leukaemia (CLL) cells.
Jose Baselga, Executive Vice President, Oncology R&D said: "These data add to the growing body of evidence to support the profile of Calquence as a selective BTK inhibitor that offers a chemotherapy-free treatment option with a favourable safety profile in chronic lymphocytic leukaemia, a life-threatening disease.
AstraZeneca Plc (LON:AZN), a multinational pharmaceutical and biopharmaceutical company, reported on Monday detailed results from the interim analysis of the phase III ASCEND trial at the European Haematology Association (EHA) Annual Congress in Amsterdam, showing Calquence (acalabrutinib) significantly prolonged the time patients live without disease progression in relapsed or refractory chronic lymphocytic leukaemia (CLL).
(Alliance News) - AstraZeneca PLC on Saturday said its drug Calquence significantly prolonged the time patients lived without disease progression in chronic lymphocytic leukaemia.
Chronic lymphocytic leukaemia. Nat Rev Dis Primers 2017; 3: 16096.
Weissmann et al., "Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia," British Journal of Haematology, vol.
Cellular Immunotherapy for Chronic Lymphocytic Leukaemia - Drug Profile 90
Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. Br J Haematol 2009; 147: 339-346, doi: 10.1111/j.1365-2141.2009.07861.x.

Full browser ?